Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46

Benzinga · 2d ago
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $39 to $46.